Your browser doesn't support javascript.
loading
Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Clifton, Katherine; Gutierrez-Barrera, Angelica; Ma, Junsheng; Bassett, Roland; Litton, Jennifer; Kuerer, Henry; Moulder, Stacy; Albarracin, Constance; Hortobagyi, Gabriel; Arun, Banu.
Afiliação
  • Clifton K; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. kkclifton@mdanderson.org.
  • Gutierrez-Barrera A; The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd., Unit 463, Houston, TX, 77030, USA. kkclifton@mdanderson.org.
  • Ma J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bassett R; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Litton J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kuerer H; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Moulder S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Albarracin C; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hortobagyi G; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Arun B; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Breast Cancer Res Treat ; 170(1): 101-109, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29470805
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína BRCA1 / Proteína BRCA2 / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína BRCA1 / Proteína BRCA2 / Neoplasias de Mama Triplo Negativas Idioma: En Ano de publicação: 2018 Tipo de documento: Article